Drugs / AZD8418
last change Mar 2010 re-read 3 minutes ago

AZD8418

Small molecule

Investigated by
AstraZeneca

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01027234 Nov 2009 → Mar 2010 — AstraZeneca Terminated No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as AZD8418 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01027234 ↗
Modality Small molecule — CHEMBL4297355 ↗
Route Oral “single increasing oral doses” NCT01027234 ↗